​Personal Genome Diagnostics (PGDx) is Empowering the Fight Against Cancer by unlocking actionable information from the genome. We are developing an innovative portfolio of regulated tissue-based and non-invasive liquid biopsy genomic products for laboratories worldwide.

PGDx

Advancing NGS in Oncology

Robust bioinformatics pipeline
validated against 400M+ base
pairs, with state of the art
machine learning technology
​Optimized NGS assays and
proprietary bioinformatics
platform for both tissue and liquid biopsy
​Founded by internationally
recognized leaders in genomic
technologies who pioneered
 cancer sequencing
Comprehensive Pharma
partnering model to enable
biomarker discovery through on market companion diagnotics
Decentralized model to enable faster comprehensive results for patients​
Commercial expertise in
deploying companion
diagnostics globally
Expert team in NGS assay
development with
infrastructure and process to
support regulated IVD
products​
PGDx

Advancing NGS in Oncology

 

Robust bioinformatics pipeline validated against 400M+ base pairs, with state of the art machine learning technology
Optimized NGS assays and proprietary bioinformatics platform for both tissue and liquid biopsy
Founded by internationally recognized leadersin genomic technologies who pioneered cancersequencing
Decentralized model to enable faster comprehensive results for patients
Comprehensive Pharma partnering model to enable biomarker discovery through on market companion diagnotics
Commercial expertise in deploying companion diagnostics globally
Expert team in NGS assay development with infrastructure and process to support regulated IVD products​

Our Team

Built upon our strong academic foundation with leadership in genomics, we have assembled experts in product development, regulatory, operations and commercialization to deliver products that bring precision medicine to more patients globally.

leadership advisors

Our Vision For Precision Medicine

NOW

PGDx began as a CAP/CLIA lab to provide clinical testing services for patients and research services for Pharma and academic partners. Our expertise in cancer genome analysis ranges from sample preparation and sequencing to data analysis and interpretation. We specialize in high-throughput next-generation sequencing and use proprietary algorithms to accurately identify alterations in complex cancer genomes. 

FUTURE

​PGDx is translating our genomic expertise and technologies into tissue-based and liquid biopsy products that can be distributed to and run in molecular laboratories worldwide, bringing testing back within the patient care ecosystem. We are committed to standardizing NGS oncology solutions for laboratories, giving access to patients worldwide. 

 

Careers Team

PGDx is a team of talented individuals with a variety of backgrounds that are dedicated to advancing precision medicine in oncology through genomic technologies.

join our team

#PGDxStories: What Inspires Us